dr. crilley on the addition of rituximab to lymphoma treatment
Published 11 years ago • 1.2K plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
3:41
comorbidities and rituximab-based therapy in fl
-
1:16
dr. pamela crilley on prescribing tkis for the treatment of cml
-
4:38
an in-depth look at treatment of follicular lymphoma
-
1:25
targeted therapy for the treatment of follicular lymphoma
-
1:43
dr. pamela crilley on imatinib and second generation tkis
-
1:13
dr. andrew zelenetz on the impact of rituximab in lymphoma
-
39:36
17. targeted therapy for non-hodgkin lymphoma – dr cathy burton
-
10:27
treatment approach in follicular lymphoma
-
1:17
dr. grossbard on the role of maintenance rituximab in follicular lymphoma
-
1:16
dr. lacasce discusses the fda approval of lenalidomide/rituximab in non-hodgkin lymphoma
-
4:37
prognosis and treatment of follicular lymphoma
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
2:11
dr. lyman on rituximab biosimilars in non-hodgkin lymphoma
-
7:18
addition of targeted drug reduces risk of first-line treatment failure in advanced hodgkin lymphoma
-
1:32
deciding on rituximab versus obinutuzumab in follicular lymphoma
-
1:31
dr. leonard on lenalidomide with rituximab in follicular lymphoma
-
24:43
understanding your treatment: rituxan and bendamustine chemotherapy
-
0:51
dr. reeder on evolving role of r-chop in aggressive lymphomas
-
1:49
dr. goy on r-chop in large cell lymphoma